Pfizer Inc.

Equities

Market Closed - Nyse Other stock markets 04:01:10 2026-05-08 pm EDT			5-day change	1st Jan Change
25.68 ^USD	-1.42%		-2.47%	+3.13%

May. 09	Ireland's fiscal success faces the risk of over-reliance
May. 06	CellCentric Ltd announced that it has received $220 million in funding from a group of investors	CI

Published on 01/13/2025 at 12:45 pm EST

S&P Capital IQ

Presenter Speech
Christopher Schott (Analysts)

Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting this fireside chat with Albert Bourla, Chairman and CEO of

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

May. 09	Ireland's fiscal success faces the risk of over-reliance
May. 06	CellCentric Ltd announced that it has received $220 million in funding from a group of investors	CI
May. 06	PFIZER INC : DZ Bank reiterates its Buy rating	ZD
May. 06	PFIZER INC : UBS remains Neutral	ZD
May. 06	Novavax beats first-quarter revenue estimates on strength in vaccine deals	RE
May. 06	PFIZER INC : Jefferies reaffirms its Buy rating	ZD
May. 06	Germany says vaccine supply secure despite BioNTech production loss	RE
May. 06	Leerink Partners Adjusts Price Target on Pfizer to $28 From $26	MT
May. 06	CellCentric raises $220 million to advance blood cancer drug	RE
May. 05	Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC	MT
May. 05	Health Care Up After Earnings - Health Care Roundup	DJ
May. 05	US FDA blocked publication of COVID, shingles vaccine safety studies	RE
May. 05	PFIZER INC : JP Morgan reaffirms its Neutral rating	ZD
May. 05	Pfizer Inc., Q1 2026 Earnings Call, May 05, 2026
May. 05	Top Midday Stories: PayPal Q2 EPS Guide Undershoots Expectations, Plans 20% Workforce Cut; Palantir Shares Fall Despite Strong Earnings, Guidance	MT